Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.62 |
| ▸ | SLC1A1 | P43005 | 5/20 | 0.56 |
| ▸ | SLC1A3 | P43003 | 5/20 | 0.54 |
| ▸ | SLC1A2 | P43004 | 5/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.52 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.52 |
| ▸ | GRIK1 | P39086 | 4/20 | 0.50 |
| ▸ | GRIK2 | Q13002 | 4/20 | 0.50 |
| ▸ | GGT1 | P19440 | 2/20 | 0.50 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.50 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL148584 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| SCHEMBL4303994 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| SCHEMBL445471 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| Glycine SCHEMBL10994359 | 0.89 | SLC7A5 (0.52) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| Aspartic Acid SCHEMBL22557639 | 0.89 | SLC7A5 (0.52) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| Serine SCHEMBL6827952 | 0.89 | SLC1A1 (0.60) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| Alanine SCHEMBL10991017 | 0.89 | SLC7A5 (0.65) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| SCHEMBL600881 | 0.87 | SLC7A5 (0.68) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| SCHEMBL9545322 | 0.87 | SLC7A5 (0.68) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| SCHEMBL29024969 | 0.87 | SLC7A5 (0.68) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 25059 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094701-A | TLR3 binding bicyclic peptide ligands | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026101930-A1 | PHOSPHOGLYCOLIPIDS AND THEIR DERIVATIVES | GlycoSurf, Inc. (US) | 2026-05-15 | — | — | WO | claimed |
| WO-2026102212-A1 | MACROCYCLIC MCL-1 INHIBITORS | VANDERBILT UNIVERSITY (US) | 2026-05-15 | — | — | WO | claimed |
| EP-4719486-A1 | CONJUGATES AND USES THEREOF | Full-Life Technologies UK Limited (GB) | 2026-04-08 | — | — | EP | claimed |
| US-12583892-B2 | Conus-based toxin peptides, nucleic acids encoding same and uses thereof in modulating NMDA receptors | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LIMITED (IL) | 2026-03-24 | — | — | US | claimed |
| EP-4707307-A2 | NEW BINDING AGENT AND ASSAY FOR PIVKA | Roche Diagnostics GmbH (DE) | 2026-03-11 | — | — | EP | claimed |
| WO-2026040002-A1 | COMPOSITION AND METHOD FOR CARING FOR THE SKIN | L'OREAL (FR) | 2026-02-26 | — | — | WO | claimed |
| US-12527836-B2 | Gla domains as targeting agents | GLAdiator Biosciences, Inc. (US) | 2026-01-20 | — | — | US | claimed |
| US-12491217-B2 | Compositions and methods for promoting healthy neural development in an unborn baby | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-12-09 | — | — | US | claimed |
| US-20250339386-A1 | VITAMIN K2 FOR USE IN TREATMENT OF CORONARY ARTERY CALCIFICATION | REGION SYDDANMARK (DK) | 2025-11-06 | — | — | US | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0260277-A1 | METHOD FOR THE EXTRACTION OF A VITAMIN-K-DEPENDENT CARBOXYLASE COMPLEX AND THE USE THEREOF | RIJKSUNIVERSITEIT LIMBURG (NL) | 1988-03-23 | — | — | EP | claimed |
| WO-1987004719-A1 | METHOD FOR THE EXTRACTION OF A VITAMIN-K-DEPENDENT CARBOXYLASE COMPLEX AND THE USE THEREOF | RIJKSUNIVERSITEIT LIMBURG (NL) | 1987-08-13 | — | — | WO | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| CN-86107574-A | Compositions containing penem or carbapenem antibiotics and their use | — | 1987-05-20 | — | — | CN | claimed |
| US-4609640-A | WATER-SOLUBLE MACROMOLECULE CHELATING AGENTS | TOYO JOZO COMPANY, LTD. (JP) | 1986-09-02 | — | — | US | claimed |
| EP-0162078-A4 | METHOD FOR ISOLATING A PROTEIN FROM A MIXTURE CONTAINING SAID PROTEIN AND A CONFORMATION SPECIFIC ANTIBODY USEFUL THEREIN. | NEW ENGLAND MEDICAL CENTER INC (US) | 1986-03-18 | — | — | EP | claimed |
| EP-0162078-A1 | METHOD FOR ISOLATING A PROTEIN FROM A MIXTURE CONTAINING SAID PROTEIN AND A CONFORMATION SPECIFIC ANTIBODY USEFUL THEREIN. | NEW ENGLAND MEDICAL CENTER INC (US) | 1985-11-27 | — | — | EP | claimed |
| US-4534881-A | Inhibition of inorganic or biological CaCO3 deposition by poly amino acid derivatives | UNIVERSITY OF SOUTH ALABAMA (US) | 1985-08-13 | — | — | US | claimed |
| WO-1985001941-A1 | METHOD FOR THE PURIFICATION AND ISOLATION OF BLOOD CLOTTING PROTEINS USING CONFORMATION SPECIFIC ANTIBODIES | NEW ENGLAND MEDICAL CENTER HOSPITALS, INC. (US) | 1985-05-09 | — | — | WO | claimed |